New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2013
11:07 EDTOKE, THOR, TER, ENR, EDAPHigh option volume stocks: OKE THOR TER ENR EDAP
News For OKE;THOR;TER;ENR;EDAP From The Last 14 Days
Check below for free stories on OKE;THOR;TER;ENR;EDAP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2014
16:43 EDTOKEONEOK Partners to invest $605M-$785M in North Dakota
Subscribe for More Information
14:34 EDTEDAPEDAP TMS halted, news pending
Subscribe for More Information
07:31 EDTEDAPFDA Gastroenterology and Urology Devices Panel to hold a meeting
Subscribe for More Information
07:11 EDTENREnergizer expects Q4 organic net sales to be flat
Subscribe for More Information
07:09 EDTENREnergizer reaffirms FY14 adjusted EPS outlook $7.00-$7.25, consensus $7.08
Total company organic net sales are expected to decline in the low- to mid-single digits for FY14. Gross restructuring savings are expected to increase approximately $135M-$150M for FY14 versus the prior year; resulting in total estimated project to date savings of $235M-$250M.
07:07 EDTENREnergizer reports Q3 adjusted EPS $1.46, consensus $1.55
Subscribe for More Information
July 29, 2014
15:53 EDTENRNotable companies reporting before tomorrow's open
Subscribe for More Information
10:36 EDTTHORThoratec drops after Wells Fargo cuts estimates, downgrades shares
Subscribe for More Information
10:00 EDTTHOROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:35 EDTTHORThoratec downgraded to Market Perform from Outperform at Wells Fargo
Subscribe for More Information
July 28, 2014
15:12 EDTEDAPEDAP TMS downgraded to Market Perform from Outperform at Northland
Subscribe for More Information
14:09 EDTEDAPEDAP TMS volatility elevated into FDA meeting
EDAP TMS August option implied volatility is at 228, September is at 151, November is at 106; compared to its 26-week average of 109 according to Track Data, suggesting large price movement into an expected FDA--CDRH - gastroenterology and urology devices panel meeting on June 30.
July 25, 2014
09:13 EDTTERTeradyne shares should be bought on pullbacks, says Pacific Crest
Pacific Crest identifies Teradyne as a top pick and recommends looking for opportunities to buy the shares at a discount heading into the seasonally softer 2H14. The firm thinks the company is gaining share and it expects the company to benefit from growth in its semi test and wireless test markets. The firm keeps a $22 price target and Outperform rating on the shares.
July 24, 2014
16:36 EDTOKEONEOK to invest $365M-$470M in Oklahoma SCOOP play
Subscribe for More Information
July 23, 2014
18:34 EDTTEROn The Fly: After Hours Movers
UP AFTER EARNINGS: Fortinet (FTNT), up 7.8%... Hanesbrands (HBI), up 5.4%... 8x8 (EGHT), up 5.1%... Infinera (INFN), up 4.9%... Facebook (FB), reverses and is now trading up 5.1% following second quarter earnings conference call. NOTABLE: Twitter (TWTR), up 1.7%, LinkedIn (LNKD), up marginally, and Yelp (YELP), up 1.6% after Facebook reports second quarter results. ALSO HIGHER: Spectranetics (SPNC), up 7.1% after receiving FDA clearance for atherectomy products, Turbo-Tandem and Turbo Elite... Ariad Pharmaceuticals (ARIA), up 7.1%... Jamba (JMBA), up 3.8% after Engaged Capital reports stake in the company and announced that they had discussions with management. DOWN AFTER EARNINGS: AT&T (T), down 1.2%... Angie's List (ANGI), down 16.4%... Tripadvisor (TRIP), down 11.5%... Orchids Paper (TIS), down 7.4%... Cirrus Logic (CRUS), down 6.6%... Cliffs Natural (CLF), down 1.2%... Teradyne (TER), down 4%. ALSO LOWER: Kandi Technologies (KNDI), down 3.8% after being mentioned negatively in a Seeking Alpha blog post.
17:07 EDTTERTeradyne sees Q3 adjusted EPS 34c-43c, consensus 49c
Subscribe for More Information
17:06 EDTTERTeradyne reports Q2 adjusted EPS 54c, consensus 42c
Subscribe for More Information
16:36 EDTOKEONEOK increases quarterly dividend by 3% to 57.5c
The board increased ONEOK's quarterly cash dividend by 1.5c per share, or 3%, to 57.5c per share, effective for Q2, resulting in an annualized cash dividend of $2.30 per share. The dividend is payable August 14 to shareholders of record at the close of business August 4.
July 18, 2014
14:08 EDTEDAPEDAP TMS volatility elevated into FDA meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use